中国临床药理学杂志2018，Vol.34Issue(1)：77-80,84,5.DOI:10.13699/j.cnki.1001-6821.2018.01.021
镇静催眠药物治疗抑郁症共病失眠的研究现状
Current situation of sedative-hypnotic drugs in the treatment of patients with comorbided depression and insomnia
摘要
Abstract
Insomnia and depression are common mental disorders and there exists bidirectionality between sleep symptoms and depressive symptoms.Cognitive behavioral therapy for insomnia (CBT-I) is recommanded first in patients with accute or chronic insomnia.Phannacotherapy treatment is recommended when CBT-I is insufficient or patients are comorbided with depression or other mental diseases.Pharmacotherapy treatment options include antidepressants,benzodiazepines,non-benzodiazepines,atypical antipsychotics as monotherapy or cotherapy.The aim of the present review was to discuss the selection and clinical application of sedative-hypnotic drugs in patients with comorbid depression and insomnia.关键词
抑郁/失眠/镇静催眠药物Key words
depression/insomnia/sedative-hypnotic drugs分类
医药卫生引用本文复制引用
王占璋,尚德为,倪晓佳,卢浩扬,张明,温预关..镇静催眠药物治疗抑郁症共病失眠的研究现状[J].中国临床药理学杂志,2018,34(1):77-80,84,5.基金项目
广州市科技计划基金资助项目(2014J4100135) （2014J4100135）
广州市医药卫生科技一般引导基金资助项目(20161A011037) （20161A011037）
广州市医学重点专科基金资助项目 （）
